6505--Naproxen Tablets

The Department of Veterans Affairs National Acquisition Center seeks a single-award supplier of Naproxen tablets in six line items and varying strengths to support the VA Pharmaceutical Prime Vendor Program and other federal health agencies, with proposals due March 3, 2026, at 2:30 PM CT. The procurement carries no set-aside; it is unrestricted.

Place of performance involves pharmaceutical manufacturing and distribution to VA facilities, Department of Defense facilities under the PPV program, Indian Health Service, Bureau of Prisons, the Federal Health Care Center, and State Veteran Homes under Option 2. The contract runs for a one-year base ordering period plus four one-year option periods, with estimated total annual usage of approximately 148,859 bottles across all line items (250mg, 375mg, and 500mg tablets in 100- and 500-count bottles).

Offerors must supply a unique 11-digit National Drug Code number specific to their company for each product, maintain FDA-compliant manufacturing facilities with current good manufacturing practice certifications, and meet packaging requirements including safety caps, GS1-128 bar code labeling compatible with automated dispensing units. Distributors must provide a Letter of Commitment from the manufacturer. Non-small business concerns exceeding the $900,000 threshold must submit an approved subcontracting plan. Offerors must propose unit prices for all six line items across the base year and all four option years, with prices not exceeding two decimal places and including a mandatory 0.5% Cost Recovery Fee. Contractors must establish business-to-business agreements with designated PPV contractors (McKesson for VA; McKesson, Cencora, Cardinal Health, and DMS Pharmaceutical Group for DoD) within 60 days before the ordering period commences. Payment flows from PPV contractors rather than directly from the Government. The NAICS code is 325412, Pharmaceutical Preparation Manufacturing; PSC code is 6505, Drugs and Biologicals.